AU2002220968A1 - Process for the preparation of a fast dissolving dosage form - Google Patents

Process for the preparation of a fast dissolving dosage form

Info

Publication number
AU2002220968A1
AU2002220968A1 AU2002220968A AU2096802A AU2002220968A1 AU 2002220968 A1 AU2002220968 A1 AU 2002220968A1 AU 2002220968 A AU2002220968 A AU 2002220968A AU 2096802 A AU2096802 A AU 2096802A AU 2002220968 A1 AU2002220968 A1 AU 2002220968A1
Authority
AU
Australia
Prior art keywords
preparation
dosage form
fast dissolving
dissolving dosage
fast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002220968A
Other languages
English (en)
Inventor
Rajiv Malik
Deepak Murpani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of AU2002220968A1 publication Critical patent/AU2002220968A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
AU2002220968A 2000-12-15 2001-12-07 Process for the preparation of a fast dissolving dosage form Abandoned AU2002220968A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1170/DEL/2000 2000-12-15
IN1170DE2000 IN192750B (enExample) 2000-12-15 2000-12-15
PCT/IB2001/002354 WO2002047607A2 (en) 2000-12-15 2001-12-07 Process for the preparation of a fast dissolving dosage form

Publications (1)

Publication Number Publication Date
AU2002220968A1 true AU2002220968A1 (en) 2002-06-24

Family

ID=11097139

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002220968A Abandoned AU2002220968A1 (en) 2000-12-15 2001-12-07 Process for the preparation of a fast dissolving dosage form

Country Status (4)

Country Link
EP (1) EP1343481A4 (enExample)
AU (1) AU2002220968A1 (enExample)
IN (1) IN192750B (enExample)
WO (1) WO2002047607A2 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
KR100503949B1 (ko) * 2003-04-28 2005-07-26 주식회사유한양행 염산 온단세트론의 쓴맛을 효과적으로 은폐한 경구용 구강속붕해정 조성물
FR2858556B1 (fr) * 2003-08-06 2006-03-10 Galenix Innovations Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation
EP1510208A1 (en) 2003-08-22 2005-03-02 Fournier Laboratories Ireland Limited Pharmaceutical composition comprising a combination of metformin and statin
WO2005062722A2 (en) * 2003-11-21 2005-07-14 Sun Pharmaceutical Industries Limited Fexofenadine containing pharmaceutical formulation
US20090060983A1 (en) * 2007-08-30 2009-03-05 Bunick Frank J Method And Composition For Making An Orally Disintegrating Dosage Form
EP2044929A1 (en) * 2007-10-04 2009-04-08 Laboratorios del Dr. Esteve S.A. Oral fast distintegrating tablets
CA2704209C (en) 2007-10-31 2017-02-28 Mcneil-Ppc, Inc. Orally disintegrative dosage form
DE102008047910A1 (de) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tablettierhilfsstoff auf Laktose- und Cellulosebasis
US8343533B2 (en) 2009-09-24 2013-01-01 Mcneil-Ppc, Inc. Manufacture of lozenge product with radiofrequency
US20110318411A1 (en) 2010-06-24 2011-12-29 Luber Joseph R Multi-layered orally disintegrating tablet and the manufacture thereof
US8581001B2 (en) 2010-04-16 2013-11-12 Codman & Shurtleff Metformin-cysteine prodrug
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline
CN102258497B (zh) * 2011-08-18 2013-01-09 海南良方医药有限公司 一种拉米夫定片剂组合物及其制备方法
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US10842802B2 (en) 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms
CN103432091A (zh) * 2013-09-13 2013-12-11 钟术光 一种性能改善的片剂及其制备方法
EP3091966B1 (en) 2014-01-10 2019-07-31 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
PL3927314T3 (pl) 2019-02-22 2024-02-19 Catalent U.K. Swindon Zydis Limited Minimalizacja aglomeracji materiału powlekającego cząstki leku podczas przechowywania dla ustabilizowania czasów rozpadu produktów farmaceutycznych
PL3927322T3 (pl) 2019-02-22 2024-02-05 Catalent U.K. Swindon Zydis Limited Minimalizacja napowietrzania zawiesin podczas mieszania typu in-line
KR20210129649A (ko) 2019-02-22 2021-10-28 카탈렌트 유.케이. 스윈던 지디스 리미티드 이부프로펜을 포함하는 약학적 조성물의 응집, 에어레이션 최소화 및 코팅 보존
GB2585411B (en) 2019-02-22 2023-10-04 Catalent Uk Swindon Zydis Ltd Preserving functionally-coated API particles produced by solventless mixing processes in aqueous suspension
US11179331B1 (en) 2020-04-21 2021-11-23 Cure Pharmaceutcai Holding Corp Oral soluble film containing sildenafil citrate
AU2021276611A1 (en) 2020-05-18 2022-12-15 Orexo Ab New pharmaceutical composition for drug delivery
EP4188324A1 (en) 2020-07-31 2023-06-07 Catalent U.K. Swindon Zydis Limited Pharmaceutical compositions comprising coated api
JP2024541470A (ja) 2021-11-25 2024-11-08 オレクソ・アクチエボラゲット アドレナリンを含む医薬組成物
GB202117016D0 (en) 2021-11-25 2022-01-12 Orexo Ab New pharmaceutical device

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA854876B (en) * 1984-06-28 1986-08-27 Searle & Co Antacid composition
US4946684A (en) * 1989-06-20 1990-08-07 American Home Products Corporation Fast dissolving dosage forms
JP3233638B2 (ja) * 1993-07-09 2001-11-26 アール．ピー． シェーラー コーポレイション 凍結乾燥された薬投与形状物の製造方法
US5622719A (en) * 1993-09-10 1997-04-22 Fuisz Technologies Ltd. Process and apparatus for making rapidly dissolving dosage units and product therefrom
GB2293099A (en) * 1994-09-15 1996-03-20 Mailway Packaging Group Ltd Drug formulation
DE69727922T2 (de) * 1996-04-16 2005-01-20 Novartis Consumer Health S.A. Schnell zerfallende orale dosierungsform
WO1999043306A1 (en) * 1998-02-26 1999-09-02 Banyu Pharmaceutical Co., Ltd. An orally disintegrating composition and its manufacturing method
GT199900061A (es) * 1998-05-15 2000-10-14 Pfizer Formulaciones farmaceuticas.

Also Published As

Publication number Publication date
EP1343481A2 (en) 2003-09-17
WO2002047607A2 (en) 2002-06-20
IN192750B (enExample) 2004-05-15
WO2002047607A3 (en) 2003-03-20
EP1343481A4 (en) 2004-03-17

Similar Documents

Publication Publication Date Title
AU2002220968A1 (en) Process for the preparation of a fast dissolving dosage form
AU2001234999A1 (en) A process for forming a semiconductor structure
AU2002341241A1 (en) Process for the preparation of fast dissolving dosage form
HUP0402027A3 (en) Process for the preparation of a xantophyll
AU7466900A (en) A process for the preparation of h-tyr-d-ala-phe(f)-phe-nh2
AU2464401A (en) Process for the preparation of oligomeric compounds
AU2001267831A1 (en) DDS compound and process for the preparation thereof
IL160193A0 (en) Process for the preparation of a 14-hydroxynormorphinone derivative
AU2001273762A1 (en) Process for the preparation of (r)-2-alkyl-3-phenyl-1-propanols
AU2002238421A1 (en) Process for the preparation of phenethylamine derivatives
HUP0104272A3 (en) New cyclobutendione compounds, a process for their preparation and pharmaceutical compositions containing them
HUP0101875A3 (en) Process for the preparation of piperidine derivatives
AU2002229648A1 (en) A process for the preparation of citalopram
AU2827100A (en) Process for the preparation of phenylhydrazines
AU2002310898A1 (en) Process for the preparation of a polymer-amine
AU2001268641A1 (en) Cleaning tablets, and a process for the manufacture of the cleaning tablets
AU2001292578A1 (en) Pharmaceutical compounds
AU2001262575A1 (en) Process for the preparation of paper having a special appearance
AU2001282071A1 (en) Multiparticulate pharmaceutical dosage form and a method for producing the same
AU5462901A (en) Process for the preparation of (pyridinylidene)-phthalides
AU3547001A (en) Method for producing pharmaceutical dosage forms
AU2677201A (en) A process for the preparation of substituted benzophenones
IL137364A0 (en) A process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol
AU2002214977A1 (en) Tetrahydrocarbazoles, a process for the preparation of those compounds, and the use thereof
AUPQ916700A0 (en) A method of preparing a pharmaceutical composition